Whitepaper: The Disruption of the Audit Process during COVID-19
By Jens Mattuschka; Sharon Schnieder |
Post-Pandemic: Why Remote Audits are Here to Stay
In response to the impact of COVID-19, organizations across all industries are re-thinking processes and establishing creative solutions. For biopharma companies, a core focus is on maintaining continuity of medical supply while minimizing the disruption to manufacturing and services.
In this whitepaper, you'll learn the following:
- The Pros and Cons of Remote Audits
- How to Plan a Remote Audit
- What to Consider During and After a Remote Audit
Access the whitepaper now to better identify the challenges in the audit process during COVID-19 in relation to your organization.